经尿道前列腺电切术后下尿路症状的自然史:一项前瞻性观察研究
本研究前瞻性纳入50例接受经尿道前列腺电切术的男性,术前及术后2、4、6、8周完成国际前列腺症状评分。结果显示术后各时间点症状均较基线显著改善,未出现初期加重,生活质量改善与尿频、尿流细弱和夜尿症中度相关。
要点
- 术后下尿路症状未出现初期恶化,各时间点均较基线显著改善。
- 生活质量改善与刺激性及梗阻性症状混合相关。
- 术后镇痛药使用逐渐减少,14%患者因尿路感染使用抗生素。
核心结论
- 经尿道前列腺电切术后下尿路症状并未在术后初期加重,与常见临床预期相反。
- 术后生活质量改善与尿频、尿流细弱和夜尿症中度相关。
研究设计与样本
- 前瞻性观察研究,纳入50例接受经尿道前列腺电切术的男性,平均年龄70.1岁(标准差8.4,范围47-95)。
- 术前及术后2、4、6、8周完成国际前列腺症状评分,并收集年龄、体质指数、既往经尿道前列腺电切术史、切除前列腺质量、组织学、镇痛药、症状性尿路感染及非计划再入院等资料。
主要发现
- 基线平均国际前列腺症状评分为25.5分(标准差7.9),多数患者为严重症状。
- 所有时间点与基线比较均显示显著改善(重复测量方差分析,P < 0.001)。
- 刺激性症状在术后2周即较基线立即改善,并持续至最终随访。
- 生活质量改善56%,与尿频(r = 0.68)、尿流细弱(r = 0.63)和夜尿症(r = 0.61)中度相关。
- 切除前列腺质量及年龄与国际前列腺症状评分相关性差(r分别为-0.09至-0.36和0.01至0.22)。
关键数值与推荐
- 镇痛药(患者报告的对乙酰氨基酚或布洛芬)使用率在术后2、4、6、8周分别降至34%、16%、12%、8%。
- 14%患者因尿路感染使用抗生素,5%患者因血块潴留需再入院。
临床怎么用
- 术后下尿路症状预期不会初期加重,可据此告知患者并减少不必要的干预。
- 生活质量改善与刺激性和梗阻性症状均相关,评估时应综合考虑。
- 术后镇痛药使用逐渐减少,但需关注尿路感染和血块潴留导致的再入院风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the temporal changes in lower urinary tract symptoms (LUTS) following transurethral resection of prostate (TURP), assessed using fortnightly completion of the International Prostate Symptom Score (IPSS) as compared to baseline. PATIENTS AND METHODS: This was a prospective observational study. Patients completed the IPSS preoperatively and at 2, 4, 6 and 8 weeks postoperatively. Age, body mass index, prior TURP, resected prostate mass, histology, analgesia, symptomatic urinary tract infections (UTIs), and unplanned readmissions were also collected. RESULTS: A total of 50 men were enrolled in the study with a mean (SD, range) age of 70.1 (8.4, 47-95) years. The mean (SD) baseline IPSS was 25.5 (7.9) points, indicating severe symptoms in majority of patients. Significant improvement was observed across all timepoints (P < 0.001 for all comparisons vs baseline, repeated measures analysis of variance). Irritative symptoms saw an immediate improvement at 2 weeks compared to baseline, which was sustained until final follow up. Quality of life improved by 56% and was moderately correlated with frequency (r = 0.68), weak stream (r = 0.63) and nocturia (r = 0.61). Both resected prostate mass and age displayed poor correlation with IPSS symptoms (r = -0.09 to -0.36 and 0.01 to 0.22 respectively). Analgesia (patient-reported paracetamol or ibuprofen) use decreased over time to 34%, 16%, 12%, and 8% at 2, 4, 6, and 8 weeks respectively. Antibiotics for UTI were given in 14% of patients, whilst 5% required re-admission due to clot retention. CONCLUSION: Contrary to common clinician expectations, LUTS did not worsen in the initial postoperative period. Quality-of-life scores correlated with a mixture of irritative and obstructive symptoms. These findings now quantify expected rates of improvement postoperatively and allow for further investigation into tailored interventions such as pharmacotherapy to enhance patient experience and outcomes.
引用
- Thomson A, Yim A, Qin K, et al. Natural history of lower urinary tract symptoms following transurethral resection of prostate: a prospective observational study. BJU Int. 2026. PMID: 41795616. doi:10.1111/bju.70219
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。